{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:19:23Z","timestamp":1773868763169,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100025160","name":"Allievex Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100025160","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The GM2 gangliosidoses, Tay-Sachs disease and Sandhoff disease, are devastating neurodegenerative disorders caused by \u03b2-hexosaminidase A (HexA) deficiency. In the Sandhoff disease mouse model, rescue potential was severely reduced when HexA was introduced after disease onset. Here, we assess the effect of recombinant HexA and HexD3, a newly engineered mimetic of HexA optimized for the treatment of Tay-Sachs disease and Sandhoff disease. Enzyme replacement therapy was administered by repeat intracerebroventricular injections in Sandhoff disease model mice with dosing beginning before and after signs of neurodegeneration. As previously observed, HexA effectively increased the lifespan of Sandhoff disease mice by 3.5-fold only when treatment was started before onset of neurodegeneration. In contrast, HexD3 halted motor decline and ameliorated late-stage disease severity even when dosing began late, after neurodegeneration onset. Additionally, HexD3 had advantages over HexA in enzyme stability, distribution potential, and homodimer activity. Overall, our data indicate that advanced therapeutics may widen the treatment window for neurodegenerative disorders.<\/jats:p>","DOI":"10.1371\/journal.pone.0315005","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T18:49:06Z","timestamp":1735930146000},"page":"e0315005","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intracerebroventricular administration of a modified hexosaminidase ameliorates late-stage neurodegeneration in a GM2 mouse model"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0982-2137","authenticated-orcid":true,"given":"Manuel E.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoonsan","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linley","family":"Mangini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Handyside","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Giaramita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aashish","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Van Vleet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Abolhesn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica B.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Villalpando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanbin","family":"Ru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Bullens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett E.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Bunting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Aoyagi-Scharber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"2","key":"pone.0315005.ref001","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1469-8749.2011.04160.x","article-title":"GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed.","volume":"54","author":"NJ Smith","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"pone.0315005.ref002","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13023-020-01354-3","article-title":"Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.","volume":"15","author":"N Lyn","year":"2020","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"pone.0315005.ref003","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1542\/peds.2006-0588","article-title":"The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported","volume":"118","author":"GH Maegawa","year":"2006","journal-title":"Pediatrics"},{"key":"pone.0315005.ref004","doi-asserted-by":"crossref","first-page":"15057","DOI":"10.1038\/mtm.2015.57","article-title":"Construction of a hybrid beta-hexosaminidase subunit capable of forming stable homodimers that hydrolyze GM2 ganglioside in vivo","volume":"3","author":"MB Tropak","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"5","key":"pone.0315005.ref005","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1172\/JCI85300","article-title":"Protease-resistant modified human beta-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model","volume":"126","author":"K Kitakaze","year":"2016","journal-title":"J Clin Invest"},{"issue":"7","key":"pone.0315005.ref006","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/hum.2016.013","article-title":"Novel vector design and hexosaminidase variant enabling self-complementary adeno-associated virus for the treatment of Tay-Sachs disease","volume":"27","author":"S Karumuthil-Melethil","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"7","key":"pone.0315005.ref007","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/hum.2016.015","article-title":"Systemic gene transfer of a hexosaminidase variant using an scAAV9.47 vector corrects GM2 gangliosidosis in Sandhoff mice","volume":"27","author":"KJ Osmon","year":"2016","journal-title":"Hum Gene Ther"},{"issue":"3","key":"pone.0315005.ref008","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/hmg\/ddt459","article-title":"Reversibility of neuropathology in Tay-Sachs-related diseases","volume":"23","author":"MB Cachon-Gonzalez","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"7","key":"pone.0315005.ref009","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/mt.2013.86","article-title":"Therapeutic response in feline Sandhoff disease despite immunity to intracranial gene therapy","volume":"21","author":"AM Bradbury","year":"2013","journal-title":"Mol Ther"},{"key":"pone.0315005.ref010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.expneurol.2014.09.020","article-title":"Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease","volume":"263","author":"AM Bradbury","year":"2015","journal-title":"Exp Neurol"},{"issue":"2","key":"pone.0315005.ref011","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"K Sango","year":"1995","journal-title":"Nat Genet"},{"issue":"5","key":"pone.0315005.ref012","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1194\/jlr.M057851","article-title":"Bis(monoacylglycero)phosphate: a secondary storage lipid in the gangliosidoses.","volume":"56","author":"Z Akgoc","year":"2015","journal-title":"J Lipid Res"},{"issue":"12","key":"pone.0315005.ref013","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1523\/JNEUROSCI.5981-10.2011","article-title":"Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder","volume":"31","author":"ME Lopez","year":"2011","journal-title":"J Neurosci"},{"issue":"3","key":"pone.0315005.ref014","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice.","volume":"1","author":"RM Deacon","year":"2006","journal-title":"Nat Protoc."},{"issue":"12","key":"pone.0315005.ref015","doi-asserted-by":"crossref","first-page":"e0243006","DOI":"10.1371\/journal.pone.0243006","article-title":"Natural history study of glycan accumulation in large animal models of GM2 gangliosidoses.","volume":"15","author":"C Cavender","year":"2020","journal-title":"PLoS One."},{"issue":"48","key":"pone.0315005.ref016","doi-asserted-by":"crossref","first-page":"33674","DOI":"10.1074\/jbc.M804288200","article-title":"Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling","volume":"283","author":"R Lawrence","year":"2008","journal-title":"J Biol Chem"},{"key":"pone.0315005.ref017","first-page":"100524","article-title":"Characterization of glycan substrates accumulating in GM1 gangliosidosis","volume":"21","author":"R Lawrence","year":"2019","journal-title":"Mol Genet Metab Rep"},{"issue":"8","key":"pone.0315005.ref018","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/pmic.201100463","article-title":"Using iRT, a normalized retention time for more targeted measurement of peptides","volume":"12","author":"C Escher","year":"2012","journal-title":"Proteomics"},{"issue":"5","key":"pone.0315005.ref019","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nmeth.1584","article-title":"mProphet: automated data processing and statistical validation for large-scale SRM experiments.","volume":"8","author":"L Reiter","year":"2011","journal-title":"Nat Methods"},{"issue":"9","key":"pone.0315005.ref020","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/glycob\/cwp080","article-title":"Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene","volume":"19","author":"H Akeboshi","year":"2009","journal-title":"Glycobiology"},{"issue":"8","key":"pone.0315005.ref021","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/mt.2010.113","article-title":"Introduction of an N-glycan sequon into HEXA enhances human beta-hexosaminidase cellular uptake in a model of Sandhoff disease","volume":"18","author":"K Matsuoka","year":"2010","journal-title":"Mol Ther"},{"issue":"1","key":"pone.0315005.ref022","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0925-4439(02)00221-1","article-title":"A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside","volume":"1637","author":"R Sharma","year":"2003","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"pone.0315005.ref023","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1093\/clinchem\/44.10.2094","article-title":"Evaluation of the lysosome-associated membrane protein LAMP-2 as a marker for lysosomal storage disorders","volume":"44","author":"CT Hua","year":"1998","journal-title":"Clin Chem"},{"issue":"3","key":"pone.0315005.ref024","first-page":"434","article-title":"In situ assessment of beta-hexosaminidase activity","volume":"19","author":"HD Lacorazza","year":"1995","journal-title":"Biotechniques"},{"issue":"17","key":"pone.0315005.ref025","article-title":"GM2 gangliosidoses: clinical features, pathophysiological aspects, and current therapies.","volume":"21","author":"AF Leal","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"3","key":"pone.0315005.ref026","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.1976.tb10401.x","article-title":"Oligosaccharide storage in brains from patients with fucosidosis, GM1-gangliosidosis and GM2-gangliosidosis (Sandhoff\u2019s disease).","volume":"27","author":"GC Tsay","year":"1976","journal-title":"J Neurochem"},{"issue":"1","key":"pone.0315005.ref027","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ab.2005.06.042","article-title":"Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides","volume":"345","author":"SL Ramsay","year":"2005","journal-title":"Anal Biochem"},{"issue":"9","key":"pone.0315005.ref028","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1373\/clinchem.2012.201053","article-title":"Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases","volume":"59","author":"B Xia","year":"2013","journal-title":"Clin Chem"},{"issue":"2","key":"pone.0315005.ref029","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/gerona\/glu223","article-title":"Accessing data resources in the mouse phenome database for genetic analysis of murine life span and health span","volume":"71","author":"MA Bogue","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"pone.0315005.ref030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/hum.2017.163","article-title":"Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease","volume":"29","author":"HL Gray-Edwards","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"9","key":"pone.0315005.ref031","doi-asserted-by":"crossref","first-page":"e1002943","DOI":"10.1371\/journal.pgen.1002943","article-title":"Characterization of inducible models of Tay-Sachs and related disease.","volume":"8","author":"TJ Sargeant","year":"2012","journal-title":"PLoS Genet.PubMed Central PMCID"},{"key":"pone.0315005.ref032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.omtm.2017.05.009","article-title":"Clearance of heparan sulfate and attenuation of CNS pathology by intracerebroventricular BMN 250 in Sanfilippo type B mice","volume":"6","author":"M Aoyagi-Scharber","year":"2017","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"27","key":"pone.0315005.ref033","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1073\/pnas.0603765103","article-title":"Effective gene therapy in an authentic model of Tay-Sachs-related diseases","volume":"103","author":"MB Cachon-Gonzalez","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0315005.ref034","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.omtm.2018.10.011","article-title":"Efficacy of a bicistronic vector for correction of Sandhoff disease in a mouse model","volume":"12","author":"E Woodley","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"pone.0315005.ref035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.taap.2014.06.014","article-title":"Di-22:6-bis(monoacylglycerol)phosphate: a clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment.","volume":"279","author":"N Liu","year":"2014","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T18:49:17Z","timestamp":1735930157000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0315005"}},"subtitle":[],"editor":[{"given":"John Wing Shing","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0315005","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]}}}